Search Results

This is a behavioral health report for the United States. The report utilizes data from the National Survey on Drug Use and Health (NSDUH), the Youth and Risk Behavior Survey (YRBS), the Monitoring of the Future Survey sponsored by the National Institute on Drug Abuse and findings by the Center...

This spotlight uses data from the Drug Abuse Warning Network (DAWN) to examine emergency department visits related to suicide attempts that involved drugs. There was an overall increase in drug-related suicide attempts from 2005 to 2011 (for patients ages 12 and older). The report also examines the trends for individual...

These detailed tables show sample sizes and population estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Samples sizes and population estimates are provided by age group, gender, race/ethnicity, education level, employment status, geographic area, pregnancy status, college enrollment status, and probation/parole status.

Excel file with national estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving...

This Drug Abuse Warning Network (DAWN) short report summarizes key findings about drug-related emergency department visits between 2004 and 2011. The report includes data for illicit drugs, alcohol, and prescription and over-the counter medications. For medications, the report looks at misuse and abuse, adverse reactions, and accidental ingestion of drugs...

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,

This report presents data from the Treatment Episode Data Set (TEDS) by Census division and State or jurisdiction for admissions in 2011, and trend data for 2001 to 2011. It provides information on the demographic and substance abuse characteristics of admissions to treatment aged 12 and older for abuse of...

These detailed tables are population tobacco and alcohol use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Tobacco products include cigarettes, smokeless tobacco, cigars, and pipe tobacco. Alcohol use includes binge and heavy alcohol use. Results are provided for lifetime, past year, and...

These detailed tables present totals and prevalence estimates of substance use initiation from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants...

This report presents current and prior methodological approaches for estimating the prevalence of serious mental illness (SMI) and any mental illness (AMI) among adults aged 18 or older using 2008 to 2012 National Survey on Drug Use and Health (NSDUH) data. Revised SMI and AMI estimates for 2012 are presented...

This publication provides behavioral health statistics at the national and state levels from multiple data sources, including the National Survey on Drug Use and Health, the National Health Interview Survey, the Medical Expenditures Panel Survey, the National Association of State Mental Health Program Directors, as well as peer-reviewed journal articles.

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.

These detailed tables are population illicit drug use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for...

This issue of the National Survey on Drug Use and Health (NSDUH) Report presents combined 2008 to 2010 data to examine the prevalence of past year major depressive episode (MDE) among full-time college students and other young adults aged 18 to 22. Data on past year MDE, severity of impairment...

This spotlight report describes the risks of combining the drug Ecstasy (also known as MDMA or methylenedioxymethamphetamine) with alcohol. For emergency department patients aged 20 and younger, it provides the number of emergency department visits that involved Ecstasy, and the percentage of Ecstasy-related visits that involved alcohol for the years...